GlassScriptPhysician profile
Ben Holm
NPI 1588077580
$1,080.20
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $80.46 · 2023: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978 · Education: $22.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.58 |
| Education | $22.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $357.37 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $195.51 | 2023 | Dupixent |
| Janssen Biotech, INC. | $120.93 | 2022-2023 | Stelara, Remicade, Simponi Aria |
| Gilead Sciences, INC. | $107.06 | 2022-2023 | |
| Qol Medical, LLC | $84.70 | 2023 | Sucraid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.20 | 2023 | Trulance, Plenvu, Xifaxan |
| Ironwood Pharmaceuticals, INC | $46.35 | 2023 | Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $43.43 | 2023 | Entyvio |
| Celgene Corporation | $31.33 | 2023 | Zeposia |
| Genzyme Corporation | $23.00 | 2023 | |
| Braintree Laboratories, INC. | $13.32 | 2023 | Sutab |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Holm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.